A Silver Lining for Patients with French-Made PIP Breast Implants
Before: 48-year-old woman who lost 160 lbs. after bariatric surgery and after becoming an avid cyclist
After a tummy tuck.
Let's be honest. We have all seen somebody who has had plastic surgery, and whom we can hardly tell whether there is a difference. We squirm with that facelift patient, "Um. Er. You look...er..better(?)" We try our best to wriggle out of the discussion.
I never feel that way with my weight-loss patients. Abdominoplasties, body lifts, brachioplasties, breast lifts, etc., on bariatric patients typically create dramatic improvements. The results are not subtle.
About 11 months ago, I blogged about that...
...were about to get more competition from the newest kid on the block, Xeomin. http://www.pickartplasticsurgeryblog.com/2010/08/fda-approves-xeomin-the-3rd-botox.html
On August 2, 2010, the FDA approved Xeomin for treatment for cervical dystonia (neck spasms) and blepharospasm (excessive eyelid contractions). Late last week, on July 21, the FDA approved Xeomin for "the temporary improvement in appearance of moderate to severe glabellar lines in adult patients."
Xeomin is thus the third botulinum neurotoxin type A (BoNT-A) to enter the marketplace. However, it is not expected to be available to physicians in the United States until the spring of 2012.
Why the delay? I don't know. I have called my Merz sales representative to get the scoop....
New research suggests that patients getting regular Botox treatments can eventually reduce wrinkles with half as many sessions.
The research, conducted at Oregon Health & Science University, in Portland, sought to determine whether less frequent Botox treatments could provide long-lasting reduction of the frown lines between the eyebrows. After a patient receives Botox injections every 4 months for 2 years, the frequency of treatments can be changed to 6 months with comparable wrinkle-reducing results and with high patient satisfaction.
So, if you like the effects of Botox, but if you hate having costly injections every 3 months, maybe you should reconsider. Try to stick with Botox 3-4 times per year for a couple of years, and then you'll probably be able to reduce your Botox treatments to just twice per year.
Oh, by the way, the study also confirmed the wrinkle-preventing effects of Botox. The study patients' wrinkles did not worsen while they used Botox. Since they could not create wrinkles, they never formed them in the first place. Terrific!
There has been a lot of hype about stem-cell therapy for facelifting. As a Board Certified Plastic Surgeon, I find those claims comical. Please don't fall victim to clever advertising.
However, the biologists have tremendously improved our understanding of cellular biology, and it looks like some of that basic science will legitimately hit the plastic surgery world soon. On June 21, 2011, the U.S. Food and Drug Administration (FDA) approved the first autologous cell therapy for purely aesthetic purposes.
The product, azficel-T (laVív), is from Fibrocell Science, Inc. According to company records, azficel-T involves a patented technology whereby fibroblasts are extracted from behind the patient's ear (via a small biopsy); sent to the Fibrocell Science laboratory; multiplied for about 3 month;s and then frozen until needed.
Over a series of 3 treatment sessions, typically 3 to 6 weeks apart, those cells are then injected back into the patient's face. The goal is to fill in creases--such as at the nasolabial folds, which would then reduce the appearance of smile lines.
In effect, azficel-T will provide a true biological solution for deep folds and wrinkles. The results should be gradual and natural-looking.
My opinion is that this technology is certainly interesting, and I will definitely invest the time and effort to become proficient with azficel-T. However, I suspect that the product will not be revolutionary. I bet that the results will not be much better than the current crop of chemical fillers (such as Juvederm and Restylane) or the current biological/stimulatory fillers (such as Sculptra). Almost certainly, azficel-T will, however, appeal to a niche of patients who demand "natural" and who want to use their own cells (rather than a lab-produced product).
The big negative will be that patients will have to have a biopsy, wait 3 months before they get their injections, and then undergo a series of treatments (rather than just one session). A long, drawn-out process will not be appealing in our "fast-food culture."
Also, azficel-T will likely be pricey. No word yet as to how it will compare with Juvederm or Restylane for ~$500-500, but I suspect that azficel-T will hurt in the wallet.
Late last week, an FDA-advisory panel overwhelmingly voted to recommend approval for Restylane's use as a lip enhancer. While the whole FDA still needs to make a final decision, they typically accede to the advisory panel.
Of course, using Restylane (or its competitor Juvederm) for lip enhancement is nothing new. Lindsay Lohan, Lisa Rinna, Lara Flynn Boyle, and Meg Ryan (among others) have each demonstrated Restylane's...er...effectiveness.
Well, those are poorly chosen examples!
Lip enhancement with Restylane and Juvederm doesn't have to be overdone, unnatural, and ridiculous. Actually, I frequently use Restylane and Juvederm to enhance lips....
Very soon, expect to see a lot of appropriate examples of lip enhancement on television and magazines. FDA approval will allow the distributors of Restylane to advertise their product!
The International Confederation for Plastic, Reconstructive, & Aesthetic Surgery (IQUAM) recently published consensus statement regarding controversies in plastic surgery. I thought that my readers might find this list interesting...
Translation: Silicone breast implants are safe. They do not cause breast cancer. They do not cause lupus, rheumatoid arthritis, psoriasis, etc.
Translation: If you have had silicone implants, feel free to breast feed your babies.
Translation: "Lipodissolve" and "LipoZap" injections have not been shown to be either effective or safe. While I know that everybody wouldn't mind getting rid of a "love handle" or two, don't submit to any unproven injection technique. Liposuction remains the gold standard.
Translation: Botox and Dysport kick ass!
Translation: Fillers are increasingly popular. Choose one of the common resorbable fillers (such as Restylane, Juvederm, and Radiesse) rather than a permanent filler (such as Artefill or liquid silicone) because the temporary fillers are safer.
Translation: Board Certified Plastic Surgeons wish that patients were protected from poorly trained injectors. However, there are few laws that limit the practices of doctors and nurses, many of whom suck. Make sure that your injector is certified by an appropriate specialty board.
(By the way, the only board recognized by the American Board of Medical Specialties to certify phyisicians in the practice of plastic surgery is the American Board of Plastic Surgery.)
Maybe.
According the IRS, if you itemize your deductions on Form 1040, Schedule A, you may be able to deduct expenses you paid that year for medical care for yourself, your spouse, and your dependents. Specifically, you may deduct the amount by which your total medical care expenses for the year exceeds 7.5% of your adjusted gross income.
Technically, deductions are allowed only for expenses primarily paid for "the prevention or alleviation of a physical or mental defect or illness." The IRS specifically states that you may not deduct "most cosmetic surgery."
However, many of the surgeries that I do are both cosmetic and functional. Examples:
So, for many cosmetic surgeries, I could honestly write a letter to the patient's accountant stating that the surgery alleviated a physical ailment, and, therefore, consideration should be given towards a tax deduction.
On January 26, 2011, the U.S. Food and Drug Administration warned about a potential association between anaplastic large cell lymphoma (ALCL) and breast implants.
No & No.
ALCL is considered a rare but aggressive type of lymphoma. Only one in 500,000 American women develop ALCL. It is even rarer in the breast itself--3 in 100 million women (without implants). Fortunately, most forms of ALCL are treatable with a cocktail of chemotherapy.
Over the past two decades, implants have not been definitively linked to rheumatalogical diseases, breast cancer, leukemia, or lymphoma. On the contrary, the safety of breast implants has been proven in a number of North American and European studies.
Like any foreign body, implants elicit a scar capsule. The body doesn't know what the artificial substance is; the immune system cannot break it down and destroy it. So, the body creates scar around the implant. That scar is known as a capsule.
In some capsules, cells have been identified that look awfully similar to ALCL--34 identified cases out of an estimated number of 5 to 10 million women with breast implants. However, none of those patients has subsequently developed the traditional constellation of findings consistent with ALCL. None have died of lymphoma/cancer.
Moreover, surgical removal of the scar capsules has definitively removed all evidence of the abnormal cells. No chemotherapy was ever necessary.
This is awfully strange. Surgery is not at all effective for traditional ALCL.
So, did those 34 women ever have ALCL or a variant of ALCL? Or did they have funny reactions to the implants in their scar capsules, which looked a lot like ALCL, but which were never ALCL in the first place?
A shark looks like a dolphin. They are both sleek and grey. They both swim and hunt fish. But they are awfully different.
ALCL is clearly a shark. It's a bad actor. But the implant-ALCL (if I should even call it that) may be a dolphin. It can look scary at first glance, but, in fact, it may not dangerous at all.
If you have breast implants, there is no need to change your routine medical care and follow-up. ALCL is very rare; it has occurred in only a very small number of the millions of women who have breast implants.
What to remember to do:
Recent Comments